Merck & Co Inc
MRKHealthcare|Drug Manufacturers - General|USA
$120.85
+0.00 (+0.00%)
DCF (FCF)
$75.40
Tangible Book
$1.76
Graham Number
$18.83
Earnings Power
$41.17
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (218)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Guindo Chirfi | Chief Marketing Officer | 2026-02-12 | SELL | 10,000 | $121.46 | $1214.6K |
| Li Dean Y | Executive VP & President, MRL | 2026-02-10 | SELL | 10,235 | $117.52 | $1202.8K |
| Zachary Jennifer | EVP, General Counsel | 2026-02-09 | SELL | 121,573 | $119.15 | $14485.4K |
| Guindo Chirfi | Chief Marketing Officer | 2026-02-09 | SELL | 10,000 | $118.41 | $1184.1K |
| Oosthuizen Johannes Jacobus | President, U.S. Market | 2026-02-06 | SELL | 15,000 | $121.87 | $1828.1K |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | 2026-02-06 | SELL | 37,685 | $120.92 | $4556.9K |
| Guindo Chirfi | Chief Marketing Officer | 2026-02-05 | SELL | 20,000 | $121.88 | $2437.6K |
| Smart Dalton E. III | SVP Fin. - Global Controller | 2026-02-04 | SELL | 6,400 | $119.68 | $766K |
| Litchfield Caroline | EVP & CFO | 2026-02-04 | SELL | 41,997 | $119.61 | $5023.3K |
| Li Dean Y | Executive VP & President, MRL | 2026-02-04 | SELL | 15,087 | $118.77 | $1791.9K |
| Davis Robert M | Chairman, CEO & President | 2026-02-04 | SELL | 47,434 | $118.04 | $5599.1K |
| Downing Cristal N | Chief Comm. & Public Afrs Ofcr | 2025-11-10 | SELL | 7,085 | $87 | $616.4K |
| Williams David Michael | EVP,Chief Info&Digital Officer | 2025-11-03 | SELL | 8,614 | $83.59 | $720K |
| Smart Dalton E. III | SVP Fin. - Global Controller | 2025-04-25 | SELL | 4,262 | $82.76 | $352.7K |
| Oosthuizen Johannes Jacobus | President, U.S. Market | 2025-02-19 | SELL | 8,500 | $84.09 | $714.8K |
| Williams David Michael | EVP,Chief Info&Digital Officer | 2025-02-13 | SELL | 6,000 | $85.34 | $512K |
| THULIN INGE G | Director | 2025-02-06 | BUY | 2,833 | $88.25 | $250K |
| Downing Cristal N | Chief Comm. & Public Afrs Ofcr | 2025-02-06 | SELL | 2,361 | $88.76 | $209.6K |
| BAKER DOUGLAS M JR | Director | 2025-02-05 | BUY | 15,000 | $88.5 | $1327.5K |
| Litchfield Caroline | EVP & CFO | 2024-02-14 | SELL | 38,291 | $125.5 | $4805.5K |
| Davis Robert M | Chairman, CEO & President | 2024-02-14 | SELL | 235,021 | $125.69 | $29539.8K |
| Romanelli Joseph | President, Human Health Int?l | 2024-02-13 | SELL | 1,000 | $124.89 | $124.9K |
| Li Dean Y | Executive VP & President, MRL | 2024-02-09 | SELL | 14,702 | $125.5 | $1845.1K |
| Williams David Michael | EVP,Chief Info&Digital Officer | 2024-02-07 | SELL | 1,451 | $127.57 | $185.1K |
| Oosthuizen Johannes Jacobus | President, U.S. Market | 2024-02-02 | SELL | 18,959 | $127.18 | $2411.2K |
| Oosthuizen Johannes Jacobus | President, U.S. Market | 2023-11-09 | SELL | 2,081 | $102.38 | $213.1K |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | 2023-11-08 | SELL | 43,823 | $105.03 | $4602.7K |
| MIZELL STEVEN | EVP, Chief HR Officer | 2023-08-14 | SELL | 4,250 | $109.01 | $463.3K |
| MIZELL STEVEN | EVP, Chief HR Officer | 2023-08-03 | SELL | 4,500 | $105.49 | $474.7K |
| Romanelli Joseph | President, Human Health Int?l | 2023-08-02 | SELL | 89 | $107.37 | $9.6K |
| Zachary Jennifer | EVP, General Counsel | 2023-05-04 | SELL | 19,141 | $117.59 | $2250.8K |
| Karachun Rita A | Sr. VP Fince-Global Controller | 2023-05-04 | SELL | 15,875 | $117.53 | $1865.8K |
| MIZELL STEVEN | EVP, Chief HR Officer | 2023-05-03 | SELL | 53,400 | $119.01 | $6355.1K |
| Williams David Michael | EVP,Chief Info&Digital Officer | 2023-05-02 | SELL | 7,509 | $116.82 | $877.2K |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | 2023-05-01 | SELL | 141,599 | $115.55 | $16361.8K |
| Davis Robert M | Chairman, CEO & President | 2023-04-28 | SELL | 143,329 | $114.93 | $16472.8K |
| Romanelli Joseph | President, Human Health Int?l | 2023-04-26 | BUY | 409 | $108.4 | $44.3K |
| Chattopadhyay Sanat | Exe V-P & Pres. MMD | 2023-04-13 | SELL | 134,055 | $115.07 | $15425.7K |
| Romanelli Joseph | President, Human Health Int?l | 2023-03-24 | SELL | 35 | $104.65 | $3.7K |
| Romanelli Joseph | President, Human Health Int?l | 2023-02-15 | SELL | 5,000 | $108.22 | $541.1K |
| MIZELL STEVEN | EVP, Chief HR Officer | 2023-02-13 | SELL | 1,815 | $109.1 | $198K |
| MIZELL STEVEN | EVP, Chief HR Officer | 2023-02-09 | SELL | 5,000 | $107 | $535K |
| MIZELL STEVEN | EVP, Chief HR Officer | 2023-02-06 | SELL | 4,436 | $104.25 | $462.5K |
| Zachary Jennifer | EVP, General Counsel | 2023-02-03 | SELL | 75,436 | $103.17 | $7782.7K |
| Chattopadhyay Sanat | Exe V-P & Pres. MMD | 2023-01-09 | SELL | 83,994 | $112.29 | $9431.7K |
| MIZELL STEVEN | EVP, Chief HR Officer | 2022-11-10 | SELL | 35,000 | $101.18 | $3541.3K |
| Oosthuizen Johannes Jacobus | President, U.S. Market | 2022-11-09 | SELL | 1,795 | $103.21 | $185.3K |
| Davis Robert M | CEO & President | 2022-11-09 | SELL | 167,613 | $102.44 | $17170.3K |
| Oosthuizen Johannes Jacobus | President, U.S. Market | 2022-11-07 | SELL | 45,561 | $99.47 | $4532K |
| FRAZIER KENNETH C | Executive Chair | 2022-11-07 | SELL | 235,769 | $99.55 | $23470.8K |
| FRAZIER KENNETH C | Executive Chair | 2022-11-04 | SELL | 470,000 | $98.66 | $46370.2K |
| FRAZIER KENNETH C | Executive Chair | 2022-11-02 | SELL | 600,000 | $99.86 | $59916K |
| FRAZIER KENNETH C | Executive Chair | 2022-10-31 | SELL | 867,084 | $100.44 | $87089.9K |
| Chattopadhyay Sanat | Exe V-P & Pres. MMD | 2022-10-28 | SELL | 100,292 | $100.1 | $10039.2K |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | 2022-10-28 | SELL | 164,557 | $100.26 | $16498.5K |
| Karachun Rita A | Sr. VP Fince-Global Controller | 2022-10-28 | SELL | 31,997 | $100.34 | $3210.6K |
| MIZELL STEVEN | EVP, Chief HR Officer | 2022-10-28 | SELL | 25,000 | $99.63 | $2490.8K |
| Oosthuizen Johannes Jacobus | President, U.S. Market | 2022-10-28 | SELL | 3,633 | $100.21 | $364.1K |
| Zachary Jennifer | EVP, General Counsel | 2022-10-28 | SELL | 165,255 | $99.38 | $16423K |
| FRAZIER KENNETH C | Executive Chair | 2021-11-09 | SELL | 663,881 | $82.26 | $54610.9K |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | 2021-11-04 | SELL | 29,782 | $90.4 | $2692.3K |
| Litchfield Caroline | EVP & CFO | 2021-11-04 | SELL | 18,335 | $91 | $1668.5K |
| Karachun Rita A | Sr. VP Fince-Global Controller | 2021-11-03 | SELL | 25,000 | $88.45 | $2211.3K |
| Gerberding Julie L. | EVP, Chief Patient Officer | 2021-11-01 | SELL | 96,270 | $87.91 | $8463.1K |
| Clyburn Frank | EVP & Pres ? Human Health | 2021-11-01 | SELL | 39,762 | $87.87 | $3493.9K |
| Chattopadhyay Sanat | Exe V-P & Pres. MMD | 2021-10-29 | SELL | 24,619 | $87.32 | $2149.7K |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | 2021-10-29 | SELL | 135,405 | $87.56 | $11856.1K |
| Clyburn Frank | EVP & Pres ? Human Health | 2021-05-10 | SELL | 19,324 | $78.32 | $1513.5K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2020-11-09 | SELL | 280,000 | $81.42 | $22797.6K |
| Davis Robert M | EVP, Global Svcs & CFO | 2020-10-05 | SELL | 251,273 | $81.03 | $20360.7K |
| Chattopadhyay Sanat | Exe V-P & Pres. MMD | 2020-08-13 | SELL | 10,380 | $83.01 | $861.6K |
| Clyburn Frank | EVP, Chief Commercial Officer | 2020-08-05 | SELL | 18,876 | $81.55 | $1539.3K |
| Gerberding Julie L. | EVP Strat Comm, GI Pub Policy | 2020-07-17 | SELL | 36,285 | $80 | $2902.8K |
| BRUN LESLIE A | Director | 2020-05-07 | SELL | 5,000 | $75.46 | $377.3K |
| WEEKS WENDELL P | Director | 2020-05-07 | SELL | 5,000 | $76.02 | $380.1K |
| Gerberding Julie L. | EVP Strat Comm, GI Pub Policy | 2020-01-13 | SELL | 102,073 | $89.34 | $9119.2K |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | 2019-08-09 | SELL | 38,126 | $85.02 | $3241.5K |
| Davis Robert M | EVP, Global Svcs & CFO | 2019-06-25 | SELL | 216,718 | $85.43 | $18514.2K |
| Clyburn Frank | EVP, Chief Commercial Officer | 2019-05-07 | SELL | 25,000 | $77.73 | $1943.3K |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | 2019-05-03 | SELL | 35,000 | $80 | $2800K |
| Davis Robert M | EVP, Global Svcs & CFO | 2019-03-25 | SELL | 192,572 | $82.38 | $15864.1K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2019-03-20 | SELL | 192,736 | $82.05 | $15814K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2019-03-13 | SELL | 18,725 | $82 | $1535.5K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2019-03-05 | SELL | 20,105 | $82 | $1648.6K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2019-02-22 | SELL | 95,953 | $80.01 | $7677.2K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2019-02-19 | SELL | 135,613 | $80.03 | $10853.1K |
| Karachun Rita A | Sr. VP Fince-Global Controller | 2019-02-14 | SELL | 64,662 | $78.96 | $5105.7K |
| WEEKS WENDELL P | Director | 2019-02-13 | SELL | 5,000 | $78.71 | $393.6K |
| Chattopadhyay Sanat | Exe V-P & Pres. MMD | 2019-02-12 | SELL | 73,727 | $78.62 | $5796.4K |
| BRUN LESLIE A | Director | 2019-02-08 | SELL | 3,052 | $77.22 | $235.7K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2019-02-05 | SELL | 231,566 | $78.08 | $18080.7K |
| GLOCER THOMAS H | Director | 2019-02-04 | SELL | 10,000 | $75.96 | $759.6K |
| PERLMUTTER ROGER M | Exe V-P & Pres, MRL | 2018-11-08 | SELL | 225,443 | $75.27 | $16969.1K |
| Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | 2018-11-07 | SELL | 36,218 | $75.14 | $2721.4K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2018-11-01 | SELL | 277,879 | $73.81 | $20510.2K |
| Watson Ashley | SVP Chief Ethics & Com Officer | 2018-10-31 | SELL | 47,036 | $74.33 | $3496.2K |
| DeLuca Richard R. | EVP&Pres, Merck Animal Health | 2018-10-30 | SELL | 25,467 | $72 | $1833.6K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2018-10-02 | SELL | 279,850 | $72.07 | $20168.8K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2018-09-18 | SELL | 279,851 | $70.08 | $19612K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2018-09-17 | SELL | 107,360 | $70.18 | $7534.5K |
| Chattopadhyay Sanat | Exe V-P & Pres. MMD | 2018-08-03 | SELL | 29,208 | $65.2 | $1904.4K |
| Karachun Rita A | Sr. VP Fince-Global Controller | 2018-08-02 | SELL | 5,000 | $65.01 | $325.1K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2018-07-31 | SELL | 228,091 | $65 | $14825.9K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2018-06-18 | SELL | 134,094 | $61 | $8179.7K |
| Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | 2018-05-15 | SELL | 9,972 | $59.66 | $594.9K |
| GRADDICK WEIR MIRIAN M | Exe V-P, HR | 2018-04-16 | SELL | 24,000 | $58 | $1392K |
| WEEKS WENDELL P | Director | 2018-02-09 | SELL | 5,000 | $53.57 | $267.9K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2018-01-16 | SELL | 101,602 | $61.63 | $6261.7K |
| Holston Michael J | EVP, General Counsel | 2018-01-16 | SELL | 12,500 | $61.63 | $770.4K |
| GRADDICK WEIR MIRIAN M | Exe V-P, HR | 2018-01-16 | SELL | 65,000 | $61.35 | $3987.8K |
| GRADDICK WEIR MIRIAN M | Exe V-P, HR | 2018-01-16 | SELL | 68,000 | $61.2 | $4161.6K |
| GLOCER THOMAS H | Director | 2017-11-08 | SELL | 5,000 | $56.2 | $281K |
| KIDDER C ROBERT | Director | 2017-05-12 | SELL | 5,000 | $63.54 | $317.7K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2017-04-03 | SELL | 53,850 | $63.48 | $3418.4K |
| Karachun Rita A | Sr. VP Fince-Global Controller | 2017-02-14 | SELL | 2,954 | $64.73 | $191.2K |
| RUSSO PATRICIA F | Director | 2017-02-08 | SELL | 5,000 | $64.42 | $322.1K |
| WEEKS WENDELL P | Director | 2017-02-06 | SELL | 5,000 | $64.51 | $322.6K |
| WENDELL PETER C | Director | 2017-02-03 | SELL | 15,000 | $63.69 | $955.4K |
| Holston Michael J | EVP, General Counsel | 2017-02-03 | SELL | 91,959 | $63.96 | $5881.7K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2017-02-03 | SELL | 36,335 | $63.73 | $2315.6K |
| Cech Thomas R | Director | 2017-02-03 | SELL | 5,000 | $63.42 | $317.1K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2016-11-10 | SELL | 140,000 | $65.03 | $9104.2K |
| Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | 2016-11-07 | SELL | 85,523 | $60.02 | $5133.1K |
| LAZARUS ROCHELLE B | Director | 2016-11-02 | SELL | 20,000 | $59.06 | $1181.2K |
| WENDELL PETER C | Director | 2016-11-02 | SELL | 5,000 | $59.5 | $297.5K |
| GRADDICK WEIR MIRIAN M | Exe V-P, HR | 2016-10-03 | SELL | 40,800 | $62.07 | $2532.5K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2016-09-01 | SELL | 39,200 | $62.61 | $2454.3K |
| Golestani Clark | EVP & Chief Info Officer | 2016-08-10 | SELL | 3,000 | $63.03 | $189.1K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2016-08-05 | SELL | 392,000 | $61.81 | $24229.5K |
| AMBROSE ADELE D | Sr.V-P & Chief Comuns Officer | 2016-08-04 | SELL | 7,000 | $57.8 | $404.6K |
| GRADDICK WEIR MIRIAN M | Exe V-P, HR | 2016-07-05 | SELL | 45,000 | $57.99 | $2609.6K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2016-07-05 | SELL | 60,000 | $58 | $3480K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2016-07-01 | SELL | 50,000 | $57.69 | $2884.5K |
| GRADDICK WEIR MIRIAN M | Exe V-P, HR | 2016-07-01 | SELL | 30,000 | $57.49 | $1724.7K |
| Golestani Clark | EVP & Chief Info Officer | 2016-05-20 | SELL | 39,877 | $54.79 | $2184.9K |
| Holston Michael J | EVP, General Counsel | 2016-05-10 | SELL | 100,021 | $54.5 | $5451.1K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2016-04-14 | SELL | 131,040 | $56.11 | $7352.7K |
| WEEKS WENDELL P | Director | 2015-11-04 | SELL | 5,000 | $55.53 | $277.7K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2015-10-29 | SELL | 18,666 | $54.69 | $1020.8K |
| AMBROSE ADELE D | Sr.V-P & Chief Comuns Officer | 2015-10-29 | SELL | 37,313 | $55.08 | $2055.2K |
| WENDELL PETER C | Director | 2015-10-28 | SELL | 5,000 | $54.85 | $274.3K |
| Golestani Clark | EVP & Chief Info Officer | 2015-07-31 | SELL | 31,831 | $59.09 | $1880.9K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2015-05-11 | SELL | 10,634 | $60.44 | $642.7K |
| Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | 2015-05-08 | SELL | 38,368 | $60.99 | $2340.1K |
| Kuhlik Bruce N | Exe V-P & Gen Counsel | 2015-05-04 | SELL | 56,064 | $60.2 | $3375.1K |
| Holston Michael J | EVP, Legal | 2015-04-29 | SELL | 95,624 | $59.84 | $5722.1K |
| Kuhlik Bruce N | Exe V-P & Gen Counsel | 2015-04-29 | SELL | 156,902 | $59.82 | $9385.9K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2015-02-18 | SELL | 5,164 | $58.67 | $303K |
| Deese Willie A | Exe V-P & Pres. MMD | 2015-02-11 | SELL | 135,864 | $58.56 | $7956.2K |
| WENDELL PETER C | Director | 2015-02-09 | SELL | 5,000 | $58.76 | $293.8K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2015-01-15 | SELL | 74,200 | $62.48 | $4636K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2015-01-09 | SELL | 8,840 | $62.47 | $552.2K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-12-10 | SELL | 9,846 | $60 | $590.8K |
| Kuhlik Bruce N | Exe V-P & Gen Counsel | 2014-12-08 | SELL | 50,000 | $62 | $3100K |
| LAZARUS ROCHELLE B | Director | 2014-11-26 | SELL | 10,000 | $59.63 | $596.3K |
| WEEKS WENDELL P | Director | 2014-11-24 | SELL | 5,000 | $59.13 | $295.7K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-11-10 | SELL | 10,000 | $57.98 | $579.8K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-10-10 | SELL | 9,895 | $59.73 | $591K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-09-10 | SELL | 9,814 | $60.48 | $593.6K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2014-08-25 | SELL | 22,000 | $59.7 | $1313.4K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-08-11 | SELL | 10,058 | $57 | $573.3K |
| AMBROSE ADELE D | Sr.V-P & Chief Comuns Officer | 2014-08-04 | SELL | 28,669 | $56.64 | $1623.8K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-07-10 | SELL | 9,987 | $58.03 | $579.5K |
| GRADDICK WEIR MIRIAN M | Exe V-P, HR | 2014-07-07 | SELL | 180,047 | $59.16 | $10651.6K |
| GRADDICK WEIR MIRIAN M | Exe V-P, HR | 2014-07-07 | SELL | 180,047 | $59.16 | $10651.6K |
| Deese Willie A | Exe V-P & Pres. MMD | 2014-06-27 | SELL | 72,290 | $58.26 | $4211.6K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-06-10 | SELL | 9,985 | $58.06 | $579.7K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2014-05-14 | SELL | 10,527 | $55.91 | $588.6K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-05-09 | SELL | 10,220 | $55 | $562.1K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-04-10 | SELL | 10,047 | $57.24 | $575.1K |
| Kuhlik Bruce N | Exe V-P & Gen Counsel | 2014-04-04 | SELL | 145,225 | $56.43 | $8195K |
| Golestani Clark | EVP & Chief Info Officer | 2014-02-14 | SELL | 5,990 | $55.47 | $332.3K |
| Heller Bridgette P | Exe.VP & Pres.Con.Hlth.Care | 2014-02-13 | SELL | 43,870 | $55.04 | $2414.6K |
| Canan John | Sr.V-P Finc-Global Controller | 2014-02-11 | SELL | 10,000 | $55.7 | $557K |
| FRAZIER KENNETH C | Chairman, President & CEO | 2014-02-11 | SELL | 41,520 | $54.52 | $2263.7K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2014-02-11 | SELL | 18,000 | $55.61 | $1001K |
| Deese Willie A | Exe V-P & Pres. MMD | 2014-02-10 | SELL | 50,000 | $54.68 | $2734K |
| WENDELL PETER C | Director | 2014-02-10 | SELL | 5,000 | $54.44 | $272.2K |
| WEEKS WENDELL P | Director | 2014-02-10 | SELL | 5,000 | $54.26 | $271.3K |
| Cech Thomas R | Director | 2013-10-31 | SELL | 500 | $45.13 | $22.6K |
| Deese Willie A | Exe V-P & Pres. MMD | 2013-08-07 | SELL | 50,638 | $48.55 | $2458.5K |
| AMBROSE ADELE D | Sr.V-P & Chief Comuns Officer | 2013-05-15 | SELL | 34,208 | $46.66 | $1596.1K |
| Heller Bridgette P | Exe.VP & Pres.Con.Hlth.Care | 2013-05-13 | SELL | 5,404 | $46.15 | $249.4K |
| Heller Bridgette P | Exe.VP & Pres.Con.Hlth.Care | 2013-05-07 | SELL | 54,532 | $45.08 | $2458.3K |
| Kuhlik Bruce N | Exe V-P & Gen Counsel | 2013-05-06 | SELL | 249,998 | $45.05 | $11262.4K |
| Deese Willie A | Exe V-P & Pres. MMD | 2013-05-06 | SELL | 36,204 | $45.2 | $1636.4K |
| Kuhlik Bruce N | Exe V-P & Gen Counsel | 2012-11-12 | SELL | 61,380 | $44.02 | $2701.9K |
| Schechter Adam H | EVP & Pres-Global Human Health | 2012-11-05 | SELL | 56,300 | $45.6 | $2567.3K |
| KIM PETER S | Exe V-P & Pres, MRL | 2012-11-05 | SELL | 420,000 | $45.5 | $19110K |
| Deese Willie A | Exe V-P & Pres. MMD | 2012-08-09 | SELL | 62,324 | $44.26 | $2758.5K |
| Canan John | Sr.V-P Finc-Global Controller | 2012-08-01 | SELL | 30,500 | $44.29 | $1350.8K |
| Bowles Richard S III | Exe VP&Chief Ethics & ComplOff | 2012-05-10 | SELL | 27,377 | $38.5 | $1054K |
| Bowles Richard S III | Exe VP&Chief Ethics & ComplOff | 2012-02-17 | SELL | 42,367 | $38.78 | $1643K |
| Deese Willie A | Exe V-P & Pres. MMD | 2012-02-08 | SELL | 42,466 | $38.38 | $1629.8K |
| Bowles Richard S III | Exe VP&Chief Ethics & ComplOff | 2011-11-11 | SELL | 30,000 | $35.9 | $1077K |
| WEEKS WENDELL P | Director | 2011-10-04 | SELL | 100 | $31.35 | $3.1K |
| FRAZIER KENNETH C | President & CEO | 2011-08-15 | BUY | 32,000 | $31.78 | $1017K |
| KELLOGG PETER N | Exe V-P & CFO | 2011-08-12 | BUY | 15,800 | $31.8 | $502.4K |
| KOHAN RAUL E | Exe V-P & Pres, Animal Health | 2011-05-18 | SELL | 63,881 | $37.21 | $2377K |
| Bowles Richard S III | Exe V-P & Chief Compl Officer | 2011-05-04 | SELL | 29,755 | $36.56 | $1087.8K |
| GLOCER THOMAS H | Director | 2008-05-02 | BUY | 5,000 | $39.22 | $196.1K |
| Schechter Adam H | President, Global Pharms | 2008-02-15 | SELL | 36,676 | $47.49 | $1741.7K |
| Oschmann Stefan | President, EMEA & Canada | 2007-10-30 | SELL | 25,000 | $58.02 | $1450.5K |
| Deese Willie A | President, MMD | 2007-10-26 | SELL | 2,350 | $57.35 | $134.8K |
| YARNO WENDY L | Chief Marketing Officer | 2007-10-26 | SELL | 147,174 | $57.37 | $8443.4K |
| LEWENT JUDY C | Exec.V.P.& C.F.O. | 2007-08-07 | SELL | 34,900 | $52.07 | $1817.2K |
| LEWENT JUDY C | Exec.V.P.& C.F.O. | 2007-08-06 | SELL | 5,100 | $51.51 | $262.7K |
| LEWENT JUDY C | Exec.V.P.& C.F.O. | 2007-08-02 | SELL | 10,000 | $52.02 | $520.2K |
| LEWENT JUDY C | Exec.V.P.& C.F.O. | 2007-08-01 | SELL | 8,400 | $51.19 | $430K |
| LEWENT JUDY C | Exec.V.P.& C.F.O. | 2007-08-01 | SELL | 54,600 | $50.74 | $2770.4K |
| LEWENT JUDY C | Exec.V.P.& C.F.O. | 2007-07-31 | SELL | 12,000 | $50.19 | $602.3K |
| LEWENT JUDY C | Exec.V.P.& C.F.O. | 2007-07-30 | SELL | 25,000 | $50.07 | $1251.8K |
| LEWENT JUDY C | Exec.V.P.& C.F.O. | 2007-07-26 | SELL | 50,000 | $52.15 | $2607.5K |
| CLARK RICHARD T | COB, President & CEO | 2007-05-04 | SELL | 41,050 | $52.02 | $2135.4K |
| YARNO WENDY L | Chief Marketing Officer | 2007-04-25 | SELL | 40,332 | $51.56 | $2079.5K |
| Deese Willie A | President, MMD | 2007-02-09 | SELL | 7,666 | $43.74 | $335.3K |
| COLE JOHNNETTA B | Director | 2007-02-06 | SELL | 2,110 | $44.43 | $93.7K |
| KELLEY WILLAM N | Director | 2007-02-06 | SELL | 1,964 | $44.53 | $87.5K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked